We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
DELISTED
Adverum Biotechnologies
ADVM
| $2.21M | ﹤0.01% |
42,700
+4,920
| +13% | +$275K |
2014 Q3
6 quarters
|
|
|
OMED
252
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.18M | ﹤0.01% |
215,800
+24,000
| +13% | +$282K |
2013 Q3
10 quarters
|
|
|
CRDC
253
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $2.14M | ﹤0.01% |
601,350
| – | – |
2013 Q2
11 quarters
|
|
254
DELISTED
Comerica
CMA
| $2.03M | ﹤0.01% |
53,500
| – | – |
2013 Q2
11 quarters
|
|
255
Sensient Technologies
SXT
$5.68B
| $1.9M | ﹤0.01% |
30,000
| – | – |
2015 Q3
2 quarters
|
|
256
Greif Class B
GEF.B
$4.18B
| $1.73M | ﹤0.01% |
37,000
| – | – |
2013 Q2
11 quarters
|
|
|
ESV
257
DELISTED
Ensco Rowan plc
ESV
| $1.49M | ﹤0.01% |
35,835
| – | – |
2013 Q2
11 quarters
|
|
|
SMT
258
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
| $1.46M | ﹤0.01% |
405,809
-3,926
| -1% | -$11.4K |
2013 Q2
11 quarters
|
|
|
CERN
259
DELISTED
Cerner Corp
CERN
| $1.06M | ﹤0.01% |
20,000
| – | – |
2013 Q2
11 quarters
|
|
260
OSI Systems
OSIS
$3.13B
| $1.05M | ﹤0.01% |
+16,000
| New | +$1.06M |
2016 Q1
0 quarters
|
|
261
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $929K | ﹤0.01% |
37,000
| – | – |
2015 Q3
2 quarters
|
|
262
Post Holdings
POST
$3.51B
| $825K | ﹤0.01% |
18,336
| – | – |
2014 Q3
6 quarters
|
|
263
Workday
WDAY
$47.4B
| $768K | ﹤0.01% |
10,000
| – | – |
2013 Q2
11 quarters
|
|
264
Chemours
CC
$1.94B
| $633K | ﹤0.01% |
90,400
-1,600
| -2% | -$8.04K |
2015 Q3
2 quarters
|
|
|
XNPT
265
DELISTED
XENOPORT, INC.
XNPT
| $410K | ﹤0.01% |
91,000
| – | – |
2013 Q2
11 quarters
|
|
266
A10 Networks
ATEN
$1.84B
| $207K | ﹤0.01% |
35,000
| – | – |
2014 Q4
5 quarters
|
|
267
Gen Digital
GEN
$14.9B
| – | – |
-180,000
| Closed | -$3.78M | – |
|
268
Knowles
KN
$2.95B
| – | – |
-31,235
| Closed | -$416K | – |
|
269
Ovintiv
OVV
$18.3B
| – | – |
-112,000
| Closed | -$2.85M | – |
|
270
Trex
TREX
$4.71B
| – | – |
-752,400
| Closed | -$7.16M | – |
|
271
Thomson Reuters
TRI
$46.7B
| – | – |
-172,339
| Closed | -$7.57M | – |
|
|
BRCM
272
DELISTED
BROADCOM CORP CL-A
BRCM
| – | – |
-3,677,400
| Closed | -$213M | – |
|
|
DYAX
273
DELISTED
DYAX CORPORATION
DYAX
| – | – |
-10,482,860
| Closed | -$394M | – |
|
|
UTIW
274
DELISTED
UTI WORLDWIDE INC
UTIW
| – | – |
-3,538,000
| Closed | -$24.9M | – |
|
|
BDBD
275
DELISTED
BOULDER BRANDS INC
BDBD
| – | – |
-8,670,939
| Closed | -$95.2M | – |
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.